TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.

Norimitsu Kasahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.